Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Declines By 71.9%

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large drop in short interest in August. As of August 14th, there was short interest totaling 65,075 shares, a drop of 71.9% from the July 30th total of 231,654 shares. Approximately 9.2% of the shares of the stock are short sold. Based on an average trading volume of 65,331 shares, the days-to-cover ratio is presently 1.0 days.

Analyst Ratings Changes

A number of brokerages have recently weighed in on AEMD. Wall Street Zen upgraded Aethlon Medical to a “sell” rating in a report on Saturday, August 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Aethlon Medical in a research note on Friday, July 17th. Finally, HC Wainwright reissued a “neutral” rating and set a $1.50 target price on shares of Aethlon Medical in a research report on Tuesday, August 18th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $1.50.

Institutional Trading of Aethlon Medical

An institutional investor recently bought a new stake in Aethlon Medical stock. Citadel Advisors LLC acquired a new stake in Aethlon Medical, Inc. (NASDAQ:AEMD) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 95,084 shares of the medical equipment provider’s stock, valued at approximately $71,000. Citadel Advisors LLC owned 36.57% of Aethlon Medical at the end of the most recent reporting period. Institutional investors and hedge funds own 1.99% of the company’s stock.

Aethlon Medical Stock Up 33.6%

AEMD traded up $0.73 during trading on Friday, hitting $2.90. The company’s stock had a trading volume of 35,345,151 shares, compared to its average volume of 357,323. The firm’s 50 day moving average price is $3.53 and its two-hundred day moving average price is $8.13. The stock has a market capitalization of $2.06 million, a price-to-earnings ratio of -0.08 and a beta of 1.41. Aethlon Medical has a 12 month low of $2.17 and a 12 month high of $105.00.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings data on Thursday, August 13th. The medical equipment provider reported ($4.02) earnings per share for the quarter, missing the consensus estimate of ($3.92) by ($0.10). On average, sell-side analysts forecast that Aethlon Medical will post -5.74 earnings per share for the current year.

Aethlon Medical Company Profile

Aethlon Medical, Inc (NASDAQ: AEMD) is a clinical?stage biotechnology company focused on developing novel immunotherapeutic medical devices to address life?threatening diseases. The company’s lead product candidate, the Hemopurifier®, is an extracorporeal affinity device designed to remove circulating viruses and immunosuppressive exosomes from the bloodstream. By targeting glycosylated pathogens and exosomes, Aethlon aims to restore immune function and improve patient outcomes in oncology and infectious disease settings.

The Hemopurifier platform leverages proprietary lectin affinity technology to selectively bind and eliminate harmful particles without depleting healthy blood components.